CORTROSYN

This brand name is authorized in United States. It is also authorized in Canada, Japan.

Active ingredients

The drug CORTROSYN contains one active pharmaceutical ingredient (API):

1	Tetracosactide UNII 72YY86EA29 - COSYNTROPIN
	Tetracosactide acetate consists of the first 24 amino acids occurring in the natural corticotropic hormone (ACTH) sequence and displays the same physiological properties as ACTH. In the adrenal cortex, it stimulates the biosynthesis of glucocorticoids, mineralocorticoids, and, to a lesser extent, androgens, which explains its therapeutic effect in conditions responsive to glucocorticoid treatment.
	Read more about Tetracosactide

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
CORTROSYN Powder for solution for injection	MPI, US: SPL/Old	FDA, National Drug Code (US)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
H01AA02	Tetracosactide	H Systemic hormonal preparations, excl. Sex hormones and insulins → H01 Pituitary and hypothalamic hormones and analogues → H01A Anterior pituitary lobe hormones and analogues → H01AA ACTH
Discover more medicines within H01AA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
CA	Health Products and Food Branch	00022381
JP	医薬品医療機器総合機構	2411400D2029, 2411401A3023
US	FDA, National Drug Code	0548-5900, 50090-4547, 52584-050